149 Bio, LLC
1951 NW 7th Ave Ste 600
Miami, FL 33136
149 Bio, LLC is a Miami-based biotechnology company focused on developing innovative therapeutics for kidney diseases, with a particular emphasis on integrin activators. Their lead candidate, ONT01, is a clinical-stage oral small molecule integrin CD11b agonist aimed at treating lupus nephritis.
The company utilizes its proprietary AI-enabled CellStaple Platform to identify novel antibody and small molecule therapeutics, positioning itself at the forefront of kidney disease treatment innovation. As AlloSite continues to expand, it seeks to grow its team to further advance its mission in the biopharmaceutical sector.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.